Cerebral hypoperfusion in autism spectrum disorder
Open Access
- 1 January 2018
- journal article
- review article
- Published by The Nencki Institute of Experimental Biology, Polish Academy of Sciences in Acta Neurobiologiae Experimentalis
- Vol. 78 (1) , 21-29
Abstract
Cerebral hypoperfusion, or insufficient blood flow in the brain, occurs in many areas of the brain in patients diagnosed with autism spectrum disorder (ASD). Hypoperfusion was demonstrated in the brains of individuals with ASD when compared to normal healthy control brains either using positron emission tomography (PET) or single‑photon emission computed tomography (SPECT). The affected areas include, but are not limited to the: prefrontal, frontal, temporal, occipital, and parietal cortices; thalami; basal ganglia; cingulate cortex; caudate nucleus; the limbic system including the hippocampal area; putamen; substantia nigra; cerebellum; and associative cortices. Moreover, correlations between symptom scores and hypoperfusion in the brains of individuals diagnosed with an ASD were found indicating that the greater the autism symptom pathology, the more significant the cerebral hypoperfusion or vascular pathology in the brain. Evidence suggests that brain inflammation and vascular inflammation may explain a part of the hypoperfusion. There is also evidence of a lack of normal compensatory increase in blood flow when the subjects are challenged with a task. Some studies propose treatments that can address the hypoperfusion found among individuals diagnosed with an ASD, bringing symptom relief to some extent. This review will explore the evidence that indicates cerebral hypoperfusion in ASD, as well as the possible etiological aspects, complications, and treatments.Keywords
This publication has 72 references indexed in Scilit:
- Hyperbaric oxygen treatment in autism spectrum disordersMedical Gas Research, 2012
- Brain perfusion SPECT and EEG findings in children with autism spectrum disorders and medically intractable epilepsyBrain and Development, 2010
- Global methylation profiling of lymphoblastoid cell lines reveals epigenetic contributions to autism spectrum disorders and a novel autism candidate gene, RORA , whose protein product is reduced in autistic brainThe FASEB Journal, 2010
- Mercury induces inflammatory mediator release from human mast cellsJournal of Neuroinflammation, 2010
- Increased activities of Na+/K+-ATPase and Ca2+/Mg2+-ATPase in the frontal cortex and cerebellum of autistic individualsLife Sciences, 2009
- SK Ca and IK Ca Channels, Myogenic Tone, and Vasodilator Responses in Middle Cerebral Arteries and Parenchymal ArteriolesStroke, 2009
- The effects of hyperbaric oxygen therapy on oxidative stress, inflammation, and symptoms in children with autism: an open-label pilot studyBMC Pediatrics, 2007
- Neuronal nitric oxide mediates cerebral vasodilatation during acute hypertensionBrain Research, 2007
- The relationship between 99mTc-HMPAO brain SPECT and the scores of real life rating scale in autistic childrenBrain and Development, 2002
- Carnitine requirement of vascular endothelial and smooth muscle cells in imminent ischemiaMolecular and Cellular Biochemistry, 1992